Others have demonstrated that knockdown of XIAP strongly inhibits clonogenicity of pancreatic cancer cells treated with TRAIL indicating that XIAP promotes clonogenic survival of pancreatic carcinoma cells [34]. This evidence concerns the gene TNFSF10 and exocrine pancreatic carcinoma.